This biographical article is written like a résumé .(August 2024) |
This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (October 2019) |
Dipen J Parekh | |
---|---|
Born | 1969 Mumbai, India |
Nationality | American |
Alma mater | Vanderbilt University University of Poona Memorial Sloan Kettering Cancer Center |
Known for | Robotic surgery in Urologic-Oncology |
Scientific career | |
Fields | Urologic-Oncology |
Institutions | Miller School of Medicine University of Miami |
Website | https://doctors.umiamihealth.org/provider/Dipen+J+Parekh/525779 |
Dipen J. Parekh (born in Mumbai, India) is Chief Operating Officer at the University of Miami Health System, Chairman of Urology and the Dr. Victor Politano Endowed Chair in Clinical Urology at the Miller School of Medicine at University of Miami in Miami. [1] He also serves as the Director of Robotic surgery at the University of Miami Health System. [2]
In 2013, he was awarded the American Urological Association Gold Cystoscope Award for his excellence in "establishing programs in urologic oncology and robotic surgery and outstanding contributions in transformative research". [3]
A native of Gujarat, India Parekh completed his MBBS at University of Poona, graduating in 1991. He underwent post graduate training in General Surgery (1995) and super-specialized in Urology (1998) from the University of Mumbai. He completed his residency (2004) in urology from Vanderbilt University Medical Center and a fellowship (2006) at Memorial Sloan-Kettering Cancer Center in New York City. He also has a Masters in Healthcare Administration (2012) from Trinity University, Texas. [4]
He served as the Doctors Hospital at Renaissance Distinguished University Chair in Urology and Chief of Robotic Surgery and Urologic Oncology at the University of Texas Health Science Center in San Antonio from 2007 to 2012. [5]
In 2018, Parekh published the results of a clinical trial comparing Robotic Cystectomy vs. Open Cystectomy (RAZOR) in the medical journal The Lancet. [6] The RAZOR trial provided high evidence that robotic surgery is non-inferior to traditional surgery for bladder cancer. [7]
When performing partial nephrectomy, many surgeons clamp the renal artery. Urologic dogma has been that every minute of clamp time is detrimental to long-term kidney function. Therefore, Parekh led a study investigating this by performing biopsies on clamped kidneys and found no significant long-term effects with up to 60 minutes of ischemia. [8]
Urology, also known as genitourinary surgery, is the branch of medicine that focuses on surgical and medical diseases of the urinary system and the reproductive organs. Organs under the domain of urology include the kidneys, adrenal glands, ureters, urinary bladder, urethra, and the male reproductive organs.
Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder. Symptoms include blood in the urine, pain with urination, and low back pain. It is caused when epithelial cells that line the bladder become malignant.
Cystectomy is a medical term for surgical removal of all or part of the urinary bladder. It may also be rarely used to refer to the removal of a cyst. The most common condition warranting removal of the urinary bladder is bladder cancer.
Nicholas J. Vogelzang was a medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN). He serves as medical director of the Research Executive Committee and Associate Chair of the Developmental Therapeutics and Genitourinary Committees for US Oncology Research. His research interests include clinical trials for genitourinary malignancies and mesothelioma.
Mani Menon, born 9 July 1948 in Trichur, India, is an American surgeon whose work has helped to lay the foundation for modern Robotic Cancer Surgery. He is the founding director and the Raj and Padma Vattikuti Distinguished Chair of the Vattikuti Urology Institute at the Henry Ford Hospital in Detroit, MI, where he established the first cancer-oriented robotics program in the world. Menon is widely regarded for his role in the development of robotic surgery techniques for the treatment of patients with prostate, kidney, and bladder cancers, as well as for the development of robotic kidney transplantation.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist, oncologist, and principal investigator. Before moving to the Icahn School of Medicine in 2013, he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy, treating patients with prostate, urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon, and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically, he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit; he is on such lists as America's Top Doctors, New York Magazine's Best Doctors, and Who's Who in the World. In 2012, he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology, most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
Douglas S. Scherr is an American surgeon and specialist in Urologic Oncology. He is currently the Clinical Director of Urologic Oncology at Weill Cornell Medicine. He also holds an appointment at the Rockefeller University as a Visiting Associate Physician. Scherr was the first physician at Cornell to perform a robotic prostatectomy as well as a robotic cystectomy.
Simon J. Hall is an American researcher who is the Associate Professor and Kyung Hyun Kim, M.D. Chair of Urology and Assistant Professor, Department of Gene and Cell Medicine at The Mount Sinai School of Medicine, as well as the Director of the Barbara and Maurice Deane Prostate Health and Research Center at The Mount Sinai Medical Center, both in New York City.
Dr. Michael A. Palese, is an American urologist specializing in robotic, laparoscopic and endoscopic surgery, with a special emphasis on robotic surgeries relating to kidney cancer and kidney stone disease.
Dong-A University Hospital (Korean: 동아대학교의료원) is a major general hospital affiliated with Dong-A University in Busan, South Korea.
Mark S. Soloway is an American emeritus professor of urology, known for his work on prostate, bladder and kidney cancer. From 1991 to 2010 he was professor and chairman of the University of Miami Miller School of Medicine (MSM) Department of Urology, and later became chief of urologic oncology at Memorial Hospital in Hollywood, Florida.
Michael D. Stifelman Michael D. Stifelman, M.D., is Chair of Urology at Hackensack University Medical Center, Director of Robotic Surgery at Hackensack Meridian Health, and Professor and Inaugural Chair of Urology at Hackensack Meridian School of Medicine.
Prokar Dasgupta is an Indian-born British surgeon and academic who is professor of surgery at the surgical academy at King's Health Partners, London, UK. Since 2002, he has been consultant urologist to Guy's Hospital, and in 2009 became the first professor of robotic surgery and urology at King's, and subsequently the chairman of the King's College-Vattikuti Institute of Robotic Surgery.
Narmada Prasad Gupta is an Indian urologist, medical researcher, writer and the chairman of Academics and Research Division Urology at the Medanta, the Medicity, New Delhi. He is credited with over 10,000 urological surgical procedures and the highest number of urology robotics (URobotic) surgeries in India. He is a former head of the department of urology of the All India Institute of Medical Sciences Delhi and a former president of the Urological Society of India. He received the Dr. B. C. Roy Award, the highest Indian award in the medical category, from the Medical Council of India in 2005. The government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2007, for his contributions to Indian medicine.
Thomas E. Hutson is an American medical oncologist and cancer researcher based in Dallas, Texas. He is the director of Genitourinary Oncology Program and co-director of the Urologic Cancer Research and Treatment Center at Baylor University Medical Center. He is a Professor of Medicine at the Texas A&M Health Science Center College of Medicine and serves as a chair of Genitourinary Research for US Oncology and McKesson.
The Urology Foundation (TUF) is a charity that works across the UK and Ireland with the aim of improving the knowledge and skills of surgeons who operate on diseases of the male and female urinary-tract system and the male reproductive organs and funds research to improve outcomes of all urological conditions and urological cancers.
Dan Theodorescu is an American physician and academic. He is the Director of the Samuel Oschin Comprehensive Cancer Institute at the Cedars-Sinai Medical Center and leader of Cedars-Sinai CANCER. From 2010 until 2018, Theodorescu was Director of the University of Colorado Cancer Center and a professor of Surgery-Urology. He has been appointed Paul Mellon Chair at the University of Virginia and Paul Bunn Chair and Distinguished University Professor at the University of Colorado.
Matthew E. Nielsen is an American urologist oncologist and health services researcher. He is a Full professor and Chair of Urology at the UNC School of Medicine. Nielsen joined the faculty at UNC in 2009 as a urologic oncologist and health services researcher after completing medical school and residency training at Johns Hopkins.
Gaetano Ciancio is an Italian American surgeon at the University of Miami who specializes in kidney transplant. He is the chief medical and academic officer of the Miami Transplant Institute and the director of its Kidney & Kidney-Pancreas Programs. His most significant contributions to medicine are related to surgically treating kidney cancer once it has spread to the inferior vena cava and in optimizing the immunosuppression protocol after kidney transplant.
Richard James Cote is a pathologist, academic and author. He is the Edward Mallinckrodt Professor and Chair of the Department of Pathology and Immunology at Washington University in St. Louis School of Medicine, and the Pathologist-in-Chief at Barnes Jewish Hospital.